Highest-materiality recent filing
ProtoKinetix appoints new President, forms SightPath Biotech, patents valued at $253M
Director McDonough resigned March 31; June 17: Jones, Lamp, Brunt appointed directors, Brunt as President.
ProtoKinetix CEO Clarence Smith dies in accident; CFO Guzzetta named successor
President & CEO Clarence E. Smith died in a tragic accident on November 13, 2025.
ProtoKinetix CEO Clarence Smith dies in accident; CFO Guzzetta assumes all top roles
CEO Clarence E. Smith died Nov 13, 2025 in a tragic accident; served as CEO since 2015.
On March 31, 2026, Mr. Edward McDonough, after serving many years as a trusted advisor to ProtoKinetix, Incorporated (the “Company”) under the leadership of Clarence E. Smith, notified the Board of Directors of the Company (the “Board”) of his resignation from the Board effective immediately.
On June 17, 2026, Keith Brunt, a Translational Scientist and Associate Professor of Pharmacology, in the Faculty of Medicine at Dalhousie Medicine in New Brunswick, was appointed as a director and as the president of the Company, to hold such office until his successors are duly elected and qualified.
On June 17, 2026, Keith Brunt, a Translational Scientist and Associate Professor of Pharmacology, in the Faculty of Medicine at Dalhousie Medicine in New Brunswick, was appointed as a director and as the president of the Company, to hold such office until his successors are duly elected and qualified.
On June 17, 2026, Michael Jones, of Corbin, Kentucky, and Jason Lamp, of Roswell, Georgia were appointed as directors of the Company to serve as members of the Board, and to hold such office until their successors are duly elected and qualified.
On June 17, 2026, Michael Jones, of Corbin, Kentucky, and Jason Lamp, of Roswell, Georgia were appointed as directors of the Company to serve as members of the Board, and to hold such office until their successors are duly elected and qualified.
Max materiality 0.80 · Median 0.70 · Most common event leadership